Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000081

President and CEO sold 4,806 shares at $4.38 ($21,041)

  • President and CEO acquired 10,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-01 Exercise or conversion : show line 1 in the form +10,938 227,764 D
2021-06-02 Sale : show line 2 in the form −4,806 $4.38 $21,041 222,958 D
Open-market sales · 4,806 sh · avg $4.38 · $21,041

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,938 65,625 D
Loading xslF345X03/wf-form4_162275218310282.xml…